ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Molecular monitoring of BCR-ABL transcript levels by real-time quantitative PCR is increasingly being used to diagnose the disease and assess treatment response in patients with chronic myeloid leukemia (CML).